KIDS
Price
$22.04
Change
-$1.04 (-4.51%)
Updated
May 9 closing price
Capitalization
686.7M
80 days until earnings call
SYK
Price
$380.92
Change
-$1.54 (-0.40%)
Updated
May 9 closing price
Capitalization
134.94B
81 days until earnings call
Ad is loading...

KIDS vs SYK

Header iconKIDS vs SYK Comparison
Open Charts KIDS vs SYKBanner chart's image
OrthoPediatrics
Price$22.04
Change-$1.04 (-4.51%)
Volume$130.35K
Capitalization686.7M
Stryker
Price$380.92
Change-$1.54 (-0.40%)
Volume$758.79K
Capitalization134.94B
KIDS vs SYK Comparison Chart
Loading...
KIDS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KIDS vs. SYK commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KIDS is a StrongBuy and SYK is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 11, 2025
Stock price -- (KIDS: $22.04 vs. SYK: $380.92)
Brand notoriety: KIDS and SYK are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: KIDS: 80% vs. SYK: 43%
Market capitalization -- KIDS: $686.7M vs. SYK: $134.94B
KIDS [@Medical Specialties] is valued at $686.7M. SYK’s [@Medical Specialties] market capitalization is $134.94B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KIDS’s FA Score shows that 1 FA rating(s) are green whileSYK’s FA Score has 3 green FA rating(s).

  • KIDS’s FA Score: 1 green, 4 red.
  • SYK’s FA Score: 3 green, 2 red.
According to our system of comparison, SYK is a better buy in the long-term than KIDS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KIDS’s TA Score shows that 4 TA indicator(s) are bullish while SYK’s TA Score has 7 bullish TA indicator(s).

  • KIDS’s TA Score: 4 bullish, 6 bearish.
  • SYK’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, SYK is a better buy in the short-term than KIDS.

Price Growth

KIDS (@Medical Specialties) experienced а +2.99% price change this week, while SYK (@Medical Specialties) price change was +0.71% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.49%. For the same industry, the average monthly price growth was +3.17%, and the average quarterly price growth was -3.96%.

Reported Earning Dates

KIDS is expected to report earnings on Jul 30, 2025.

SYK is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Medical Specialties (-1.49% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SYK($135B) has a higher market cap than KIDS($687M). KIDS has higher P/E ratio than SYK: KIDS (232.56) vs SYK (42.99). SYK YTD gains are higher at: 6.041 vs. KIDS (-4.918). SYK has higher annual earnings (EBITDA): 4.93B vs. KIDS (-8.38M). SYK has more cash in the bank: 3.05B vs. KIDS (80.3M). KIDS has less debt than SYK: KIDS (10.1M) vs SYK (13B). SYK has higher revenues than KIDS: SYK (20.5B) vs KIDS (149M).
KIDSSYKKIDS / SYK
Capitalization687M135B1%
EBITDA-8.38M4.93B-0%
Gain YTD-4.9186.041-81%
P/E Ratio232.5642.99541%
Revenue149M20.5B1%
Total Cash80.3M3.05B3%
Total Debt10.1M13B0%
FUNDAMENTALS RATINGS
KIDS vs SYK: Fundamental Ratings
KIDS
SYK
OUTLOOK RATING
1..100
1018
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
19
Undervalued
PROFIT vs RISK RATING
1..100
10010
SMR RATING
1..100
9054
PRICE GROWTH RATING
1..100
7946
P/E GROWTH RATING
1..100
517
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SYK's Valuation (19) in the Medical Specialties industry is significantly better than the same rating for KIDS (91). This means that SYK’s stock grew significantly faster than KIDS’s over the last 12 months.

SYK's Profit vs Risk Rating (10) in the Medical Specialties industry is significantly better than the same rating for KIDS (100). This means that SYK’s stock grew significantly faster than KIDS’s over the last 12 months.

SYK's SMR Rating (54) in the Medical Specialties industry is somewhat better than the same rating for KIDS (90). This means that SYK’s stock grew somewhat faster than KIDS’s over the last 12 months.

SYK's Price Growth Rating (46) in the Medical Specialties industry is somewhat better than the same rating for KIDS (79). This means that SYK’s stock grew somewhat faster than KIDS’s over the last 12 months.

KIDS's P/E Growth Rating (5) in the Medical Specialties industry is in the same range as SYK (17). This means that KIDS’s stock grew similarly to SYK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KIDSSYK
RSI
ODDS (%)
Bullish Trend 3 days ago
74%
Bearish Trend 3 days ago
67%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
49%
Momentum
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
60%
MACD
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
51%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
59%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
70%
Bullish Trend 3 days ago
53%
Advances
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 7 days ago
56%
Declines
ODDS (%)
Bearish Trend 12 days ago
81%
Bearish Trend 3 days ago
52%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 5 days ago
69%
Aroon
ODDS (%)
Bearish Trend 3 days ago
78%
Bullish Trend 3 days ago
47%
View a ticker or compare two or three
Ad is loading...
KIDS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JABIX12.040.11
+0.92%
JHancock Real Estate Securities R6
JDEZX14.160.06
+0.43%
PGIM Jennison Global Equity Income Z
FCPCX27.550.04
+0.15%
Fidelity Advisor Intl Cap App C
HDCEX9.200.01
+0.11%
Rational Equity Armor Fund C
DGYGX36.890.01
+0.03%
BNY Mellon Appreciation Y